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“Ethnopharmacological” use of roots of Boerhaavia diﬀusa (B. diﬀusa) in the treatment of epilepsy in Nigerian folk medicine
and reports showing the presence of a calcium channel antagonistic compound “liriodendrin” in its roots, led us to undertake
the present study. The study was designed to investigate the methanolic root extract of B. diﬀusa and its diﬀerent fractions
including liriodendrin-rich fraction for exploring the possible role of liriodendrin in its anti-convulsant activity. Air-dried roots of
B.diﬀusawereextractedwithmethanolbycoldmaceration.Themethanolsolublefractionofextractthusobtainedwassuccessively
extractedtoobtainliriodendrin-richfractionandtwosidefractions,thatis,chloroformfractionandphenolic compoundfraction.
Anti-convulsant activity of methanolic extract (1000, 1500 and 2000mgkg−1, intraperitoneally (i.p.)) and its diﬀerent fractions,
that is, liriodendrin-rich fraction (10, 20 and 40mgkg−1, i.p., chloroform fraction (20mgkg−1, i.p.) and phenolic compound
fraction(1mgkg−1,i.p.)werestudiedinpentylenetetrazol(PTZ)-inducedseizures(75mgkg−1,i.p.).Thecrudemethanolicextract
of B. diﬀusa and only its liriodendrin-rich fraction showed a dose-dependent protection against PTZ-induced convulsions. The
liriodendrin-rich fraction also showed signiﬁcant protection against seizures induced by BAY k-8644. These ﬁndings reiterated
the anti-convulsant activity of methanolic extract of B. diﬀusa roots. Furthermore, it can be concluded that the observed anti-
convulsant activity was due to its calcium channel antagonistic action as this activity was retained only in the liodendrin-rich
fraction, which has additionally been conﬁrmed by signiﬁcant anti-convulsant activity of liriodendrin-rich fraction in BAY k-
8644-induced seizures.
1.Introduction
Ayurveda is a native Indian healthcare system which is
currently used by millions of people in India, Nepal and
Sri Lanka for their day-to-day healthcare needs [1]. Boer-
haavia diﬀusa Linn. (Nyctaginaceae), commonly known as
punarnava in Sanskrit, is a creeping weed found abundantly
all over India. It has a long history of use by indigenous
and tribal people [2]. In traditional system of medicine, the
roots of Boerhaavia diﬀusa (B. diﬀusa) have been widely
usedforthetreatmentofdyspepsia,jaundice,spleenomegaly,
abdominal pain, abdominal tumors and some other types
of cancers [3]. In Charaka Samhita and Sushrita Samhita,
it is mentioned that the Ayurvedic preparations made from
punarnava—namely,punarnavastakakvath,punarnavakshar
and punarnava taila—were used for the treatment of various
ailments such as stomachache, anemia, cough and cold,
and used as laxative and expectorant. In Nigerian folk
medicineithasbeenwidelyusedforthetreatmentofepilepsy
[4]. Many traditional uses of B. diﬀusa as, diuretic [5],
anti-ﬁbrinolytic [6], anti-bacterial [7], hepatoprotectant [8],
anti-helmintic, febrifuge, anti-leprotic, anti-asthmatic, anti-
scabies, anti-urethritis [9], anti-convulsant [10], cardiotonic
[11], immunosuppressant, anti-viral and anti-oxidant [12],
anti-inﬂammatory [13], anti-diabetic [14] and anti-cancer
[15], had been validated pharmacologically.
Boerhaavia diﬀusa contains a large number of phyto-
constituents namely, ﬂavonoids, alkaloids, steroids, triter-
penoids, lipids, lignins, carbohydrates, proteins, glycopro-
teins, punarnavine, boeravinones A–F, hypoxanthine 9-l-
arabinofuranoside, ursolic acid, punarnavoside, punarnavo-
side and liriodendrin [12]. Liriodendrin was isolated from
the methanolic extract of roots of B. diﬀusa and it showed
a calcium channel antagonistic activity [16, 17]. Reports
demonstrating the use of roots of B. diﬀusa in the treatment
of epilepsy [10] and the presence of calcium channel2 Evidence-Based Complementary and Alternative Medicine
antagonistic compound “liriodendrin” in its roots led us
to hypothesize that, roots of B. diﬀusa may possess anti-
convulsantactivityduetocalciumchannelantagonisticeﬀect
of liriodendrin.
Hence the present study was designed to investigate
diﬀerent fractions of methanolic root extract of B. diﬀusa for
exploring possible role of liriodendrin in its anti-convulsant
activity.
2. Methods
2.1. Collection of Plant Material. Boerhaavia diﬀusa roots
were collected from the botanical garden of Punjabi Uni-
versity, Patiala, India. The botanical identity of the plant
material was veriﬁed and specimens were deposited at
the Herbarium, Department of Botany, Punjabi University,
Patiala, Punjab, for reference (Voucher No.: 50973).
2.2. Preparation of Liriodendrin-Rich Extract. Authenticated
roots were shade-dried, grounded to a moderately coarse
powder and were extracted as per the scheme given in
Figure 1 [17]. Brieﬂy, the dried powdered roots of the
plant (300g) were subjected to extraction with 500mL of
methanol thrice by cold extraction. The resultant methano-
lic extract was pooled and evaporated to dryness using
rotavapor. The crude methanolic extract (32g) (fraction
1) thus obtained was again dissolved in methanol (about
150mL) and the insoluble precipitate was separated by
ﬁltration which was found to be sucrose by Fehling’s; test.
The methanolic ﬁltrate thus obtained was again evaporated
todrynessusingrotavaporandtheresiduethusobtainedwas
suspended in water and fractionated by successive extraction
with chloroform and butanol to give the chloroform (frac-
tion 2), butanol and water fraction. The butanol fraction
was extracted with 1.5% aqueous hydrochloric acid at room
temperature and the insoluble material, which contained a
mixture of phenolic compounds (fraction 3), was separated
by ﬁltration and the aqueous layer obtained from butanol
fraction was pooled with aqueous layer obtained from
methanolicsolution.Thispooledaqueousfractionwasevap-
orated to dryness using rotavapor under reduced pressure.
The residue thus obtained was dissolved in ethanol and the
insoluble material was separated by ﬁltration. The ethanolic
solution was evaporated to dryness using rotavapor, giving
the liriodendrin-rich fraction (fraction 4). The diﬀerent
fractions (1, 2, 3 and 4) were stored at 4◦C and the fractions
ofmethanolicextractswereadministeredatadoseequivalent
to the eﬀective dose of crude methanolic extract based on
percentage yield of each fraction. Dose of the extract and its
fractions was prepared by dissolving a weighed quantity of
extract and fractions in dimethylsulfoxide (DMSO) and then
dispersing the resultant solution in 0.5% carboxymethylcel-
lulose (CMC) suspension (DMSO 1: CMC 9) freshly before
use and was injected intraperitoneally (i.p.). Control groups
received equal volume of vehicle (DMSO 1: CMC 9) (i.p.).
2.3. Drugs and Chemicals. All standard chemicals used in
the present study were of analytical grade. Pentylenetetrazol
(PTZ) was obtained from Sigma Chemical Company (USA),
Diazepam from Jackson Laboratories Ltd (Amritsar, India),
DMSO from Qualigens Fine Chemicals (Mumbai, India),
CMC and Methanol from S.D Fine Chem Ltd (Mumbai,
India) and BAY k-8644 from (Sigma-Aldrich, USA).
2.4. Animals. Male Swiss albino mice (Mus musculus),
weighing 25–35g obtained from Central Research Institute
Kausali, Himachal Pradesh, were used in the present study.
The animals were housed in standard cages and maintained
at room temperature with natural day and night cycles. The
animalswereallowedfreeaccesstofood(standardlaboratory
diet) and water during study. All experiments were carried
out between 07:00 and 16:00h. All procedures were con-
ductedaccordingtoCPCSEAguidelinesandapprovedbythe
Institutional Animal Ethical Committee.
2.5. Preliminary Phytochemical Screening. Crude methanolic
extract of B. diﬀusa and its fractions 2, 3 and 4 were
reconstituted in methanol to obtain 1% w/v stock solutions,
which were subjected to preliminary phytochemical screen-
ing for the presence of alkaloids (Hager’s test, Wagner’s test),
carbohydrates (Molisch’s test), reducing sugars (Fehling’s
test), saponins (Foam test), tannins (FeCl3 test), ﬂavonoids
(Alkali test), phenolic compounds (Ferric chloride test) and
proteins (Biuret test) [18].
2.6. PTZ-Induced Convulsions. Animals were divided into
12 diﬀerent groups (n = 6). Vehicle, methanolic extract
and diﬀe r e n tf r a c t i o n so fe x t r a c ta ts p e c i ﬁ e dd o s e sw e r e
administered 30min before induction of convulsions. Con-
vulsions were induced by intraperitoneal injection of PTZ
(75mgkg−1).Theanimalsweredivided intodiﬀerentgroups
as follows:
Group 1. control group (vehicle treated).
Group 2. standard group (Diazepam 4mgkg−1, i.p.).
Group 3. diazepam (1mgkg−1, i.p.).
Group 4. crude extract (fraction 1) (1000mgkg−1, i.p.).
Group 5. crude extract (fraction 1) (1500mgkg−1, i.p.).
Group 6. crude extract (fraction 1) (2000mgkg−1, i.p.).
Group 7. chloroform fraction (fraction 2) (20mgkg−1, i.p.);
Group 8. phenolic compound fraction (fraction 3)
(1mgkg−1, i.p.).
Group 9. liriodendrin-rich fraction (fraction 4) (10mgkg−1,
i.p.).Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Scheme for extraction of roots of B. diﬀusa.
Group 10. liriodendrin-rich fraction (fraction 4) (20
mgkg−1, i.p.).
Group 11. liriodendrin-rich fraction (fraction 4) (40
mgkg−1, i.p.).
Group 12. liriodendrin-rich fraction (fraction 4) (20
mgkg−1, i.p.) +Diazepam (1mgkg−1, i.p.).
In all groups the latency to clonic convulsions and
mortality was noted [19]. The severity of convulsions was
scored as follows: Each phase was given a numeric score:
unresponsiveness = 0, mild contractions = 1, clonic seizures
= 2, tonic seizures = 3a n dd e a t h= 4. The response of each
animal was scored according to the highest phase reached
and mean severity score was calculated for each group [20].
All the treated groups were compared with vehicle treated
controls respectively in order to determine the signiﬁcant
anti-convulsant activity.
2.7. BAY k-8644-Induced Seizures. In order to elucidate the
calcium channel antagonistic action of liriodendrin-rich
fraction, animals were divided into four diﬀerent groups
(n = 6). Vehicle and liriodendrin-rich fraction (10, 20
and 40mgkg−1) were administered 30min prior to the
intracerebroventricular injection of BAY k-8644 (37.5μg).
Seizures induced were rated according to the scale devised
by: stage 1, scratching and twisting of the forelimbs (score 1);
stage 2, rearing and walking (score 2); stage 3, intermittent
clonic jerks of limbs with tonic ﬂexion of fore limbs and
tail ﬂexion; stage 4, head bobbing with complex grooming
actions (licking of fur and scratching); stage 5, jumping,
squeaking and tonic extension of hind limbs; stage 6, barrel
rolling. The occurrence of clonic and tonic seizure signs
and their latency were recorded for 50min. Mortality in the
animals wasobservedfor8hafterBAYk-8644 injection [21].
The animals were divided into diﬀerent groups as follows:
Group 13. control group (vehicle-treated).
Group 14. liriodendrin-rich fraction (fraction 4) (10
mgkg−1, i.p.).
Group 15. liriodendrin-rich fraction (fraction 4) (20
mgkg−1, i.p.).
Group 16. liriodendrin-rich fraction (fraction 4) (40
mgkg−1, i.p.).
2.8. Statistical Analysis. Results were expressed as mean ±
standard error of mean (SEM). The signiﬁcance of diﬀerence
between mean was determined by one-way ANOVA test
followed by Tukey’s; test except the mortality data which was
subjected to chi-square test and the results were regarded as
signiﬁcant at P<. 05.
3. Results
3.1. Extraction and Preliminary Phytochemical Screening.
The yield of the crude methanolic extract (fraction 1)
was found to be 10.8% w/w. The yield of fraction 2 of4 Evidence-Based Complementary and Alternative Medicine
Table 1: Phytoconstituents in B. diﬀusa methanolic extract and its
various fractions.
Phytoconstituents
(test)
Crude
methano-
lic extract
[1]
Fraction
2
Fraction
3
Fraction
4
Alkaloids
Hager’s test + + −−
Carbohydrates
Molisch’s test + + − +
Tannins
FeCl3 test + −−−
Amino acids
Ninhydrin test + + −−
Saponins
Foam test + + −−
Flavonoids
Alkali test + + −−
Phenolic
compounds + − + −
+: present; −: absent.
the methanolic extract, that is, chloroform fraction was
1.32% w/w, fraction 3 (phenolic compound fraction) was
0.07% w/w and liriodendrin-rich fraction was 1.4% w/w.
Preliminary phytochemical screening showed the presence
of alkaloids, carbohydrates, reducing sugars, phenolic com-
pounds, tannins, ﬂavonoids, amino acids and saponins in
the crude methanolic extract. In case of diﬀerent fractions
obtained from the crude methanolic extract: fraction 2
showed the presence of alkaloids, carbohydrates, amino
acids and ﬂavonoids, fraction 3 showed the presence of
phenolic compounds and fraction 4 revealed the presence of
carbohydrates and amino acids (Table 1).
3.2. PTZ-Induced Convulsions. Anti-convulsant studies with
B. diﬀusa extract showed a signiﬁcant protection against
PTZ-induced convulsions in a dose-dependent manner.
There was a signiﬁcant (P<. 05) delay in the onset of
convulsions and reduction in mortality at all the three doses
of crude extract (fraction 1) (1000, 1500 and 2000mgkg−1)
in PTZ model, as compared with vehicle control group. The
diﬀerent fractions from the crude methanolic extract, that is,
fraction 2 (20mgkg−1), fraction 3 (1mgkg−1)a n df r a c t i o n
4 (10, 20 and 40mgkg−1) were also tested in PTZ model
for their possible anti-convulsant activity. Fractions 2 and 3
showednoprotectionagainstPTZ-inducedconvulsionseven
at higher doses (data not shown) and complete mortality
was observed in all of these groups. Among the diﬀerent
fractions only fraction 4 showed a signiﬁcant (P<. 05)
delay in the onset of convulsions and reduced mortality at
all the three doses of extract (10, 20 and 40mgkg−1)i n
PTZ model in a dose-dependent manner showing maximum
protection at 40mgkg−1 dose. The activity of liriodendrin-
rich extract when combined with sub-eﬀective dose of
diazepam (1mgkg−1) showed synergistic eﬀect as the eﬀect
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Figure 2: Eﬀect of liriodendrin-rich fraction on the latency of
seizures induced by BAY k-8644. aP<. 05 as compared with vehicle
control group.
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Figure 3: Eﬀect of liriodendrin-rich fraction on the severity of
seizures induced by BAY k-8644. aP<. 05 as compared with vehicle
control group.
of combined treated group was signiﬁcantly better than
either diazepam (4mgkg−1) or liriodendrin-rich fraction
(40mgkg−1) per se treatment (Table 2).
3.3. BAY k-8644-Induced Seizures. Pretreatment with
liriodendrin-rich fraction showed protection against BAY
k-8644-induced seizures. Liriodendrin-rich fraction-treated
groups showed a signiﬁcant (P<. 05) delay in the onset
(Figure 2) and reduction in the severity (Figure 3) of seizures
induced by BAY k-8644 in a dose-dependent manner as
compared with vehicle control group.
4. Discussion
In the present study PTZ was used to induce convulsions
owing to the role of calcium ion as a common mediator
in PTZ-induced convulsions [22]. This model was suitable
for testing our hypothesis that the anti-convulsant activity
of B. diﬀusa roots might be due to calcium channel
blocking eﬀect by liriodendrin. A signiﬁcant protection wasEvidence-Based Complementary and Alternative Medicine 5
Table 2: Eﬀect of diﬀerent fractions of methanolic extract of B. diﬀusa on PTZ-induced convulsions in acute treatment studies.
Treatment/dose
(mgkg−1)
Onset of
convulsions (min)
(mean ± SEM)
Number of animals
showing
convulsions
Severity score
(mean ± SEM) Mortality (%)
Vehicle control
(75mgkg−1) 1.21 ±0.06 6/6 4.00 ±0.00 100
Diazepam (4mgkg−1)N C 0 / 6 0 0
Diazepam (1mgkg−1)2 .13 ±0.07 6/6 3.66 ±0.23 66.6
Crude extract
(1000mgkg−1) 3.97 ±0.11a 4/6 3.66 ±0.21 66.6
Crude extract
(1500mgkg−1) 4.28 ±0.06a 3/6 3.33 ±0.33 50
Crude extract
(2000mgkg−1) 11.33 ±0.46a 1/6 1.66 ± 0.50a 16.6a
Chloroform fraction
(20mgkg−1) 2.10 ±0.10 5/6 3.83 ±0.17 83.3
Phenolic compound
fraction (1mgkg−1) 1.53 ±0.05 6/6 4.0 ±0.00 100
Liriodendrin-rich
fraction (10mgkg−1) 2.49 ±0.19a 4/6 3.33 ±0.33 66.6
Liriodendrin-rich
fraction (20mgkg−1) 4.20 ±0.52a 2/6 2.00 ± 0.63a 33.3a
Liriodendrin-rich
fraction (40mgkg−1) 3.07 ±0.05a 0/6 1.83 ± 0.48a 0
Liriodendrin-rich
fraction (20mgkg−1)+
Diazepam (1mgkg−1)
NC 0/6 0 0
aP<. 05 as compared with vehicle control group.
observed at all the three dose levels of crude methanolic
extract of B. diﬀusa r o o t sr e i t e r a t i n gi t se a r l i e rr e p o r t so f
anti-convulsant activity. Therefore the crude methanolic
extract was further fractionated to obtain diﬀerent fractions
of methanolic extract rich in diﬀerent phytoconstituents.
Based on the presence of diﬀerent phytoconstituents in
diﬀerent fractions of the methanolic extract we tried to
investigatethecomponentresponsibleforitsanti-convulsant
action. As reported, chloroform fraction of the methanolic
extract contains fatty acids, sterol glycosides, syringaresinol
mono-β-d-glucopyranoside and ﬂavonoids [16]. Based on
the presence of ﬂavonoids in chloroform fraction it was
hypothesized that the activity of methanolic extract might
be because of this fraction. As it has been well reported
in literature that ﬂavonoids enhance gamma amino butyric
acid (GABA) neurotransmission and GABA is the main
inhibitory neurotransmitter which is suppressed in epilepsy
[23]. Most of the anti-epileptic drugs act by enhancing
GABA neurotransmission. It is well documented that in
PTZ-induced convulsion model, PTZ exerts its convulsive
eﬀect by inhibiting the activity of GABA at GABAA receptors
[24] that is why chloroform fraction was the ﬁrst one among
other fractions of methanolic extract to be tested for its
anti-convulsant action. But this fraction failed to show any
signiﬁcant protection indicating that the anti-convulsant
activity of B. diﬀusa is not because of ﬂavonoids present in
chloroform fraction.
The third fraction of the extract containing phenolic
compounds was also evaluated in PTZ-induced convulsions
with the notion that some phenolic compounds like maltol
and other polyphenolic compounds have exhibited anti-
epileptic activity [25]. However, this fraction too failed to
show protection indicating that the anti-convulsant activity
of B.diﬀusaisnot becauseofphenolic compounds presentin
the methanolic extract.
Finally with pretreatment of fraction 4, that is,
liriodendrin-rich fraction, a maximum of 80% protection
was observed, which was in accordance with the anti-
convulsantactivityofcrudemethanolicextract.Liriodendrin
has been reported as a calcium channel blocker [16]a n ds e v -
eral studies indicate that dihydropyridine (calcium channel
antagonists) has anti-convulsant properties [26, 27]; there-
fore the anti-convulsant action of liriodendrin-rich fraction
may be due to its calcium channel antagonistic activity. In
concordance with the earlier reports of calcium channel
antagonist showing synergistic action with diazepam [28],
in the present study diazepam synergized anti-convulsant
activity of liriodendrin-rich fraction, thus indicating B.
diﬀusaasagoodadjuvanttoconventionalanti-epilepticdrug
therapy.
Attenuation of seizures induced by BAY k-8644 ﬁnally
conﬁrmed the role of calcium antagonism in the anti-
convulsant activity of liriodendrin-rich fraction of B. diﬀusa,
thus approving our hypothesis (Figure 4).6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Schematic representation of anti-convulsant mechanism
of B. diﬀusa.
5. Conclusions
The ﬁndings of the present study suggested that the
methanolic extract of B. diﬀusa roots had anti-convulsant
activity against PTZ-induced convulsions. As this activity
retained onlyinliriodendrin-rich fraction,thisconﬁrmsthat
theanti-convulsantactivityofthecrudemethanolicextractis
due to the presence of liriodendrin. Furthermore, protection
ofBAYk-8644-inducedseizuresbyliriodendrin-richfraction
substantiates that the activity of liriodendrin is due to its
calcium channel antagonistic properties.
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